Systemic iron homeostasis.

@article{Ganz2013SystemicIH,
  title={Systemic iron homeostasis.},
  author={Tomas Ganz},
  journal={Physiological reviews},
  year={2013},
  volume={93 4},
  pages={
          1721-41
        }
}
  • T. Ganz
  • Published 1 October 2013
  • Biology
  • Physiological reviews
The iron hormone hepcidin and its receptor and cellular iron exporter ferroportin control the major fluxes of iron into blood plasma: intestinal iron absorption, the delivery of recycled iron from macrophages, and the release of stored iron from hepatocytes. Because iron losses are comparatively very small, iron absorption and its regulation by hepcidin and ferroportin determine total body iron content. Hepcidin is in turn feedback-regulated by plasma iron concentration and iron stores, and… 

Figures and Tables from this paper

The iron-regulatory hormone hepcidin: a possible therapeutic target?

Regulation of the Iron Homeostatic Hormone Hepcidin.

Current understanding of the molecular mechanisms and signaling pathways involved in the control of hepcidin synthesis in the liver, a principal determinant of plasma hePCidin concentrations, are summarized.

Regulators of hepcidin expression.

Systemic iron homeostasis and erythropoiesis

This review focuses on systemic iron homeostasis in the context of erythropoiesis, a highly iron‐demanding process, and discusses the function and regulation of hepcidin by various stimuli, and highlights hePCidin‐dependent and ‐independent mechanisms that link iron utilization with maturation of ERYthroid progenitor cells.

FIVE Regulators of hepcidin expression

The present review summarizes the current understanding of the molecular mechanisms and signaling pathways contributing to hepcidin regulation by these factors and highlights the issues that still need clarification.

Modelling Systemic Iron Regulation during Dietary Iron Overload and Acute Inflammation: Role of Hepcidin-Independent Mechanisms

A mathematical model of systemic iron regulation that incorporates the dynamics of organ iron pools as well as regulation by the hepcidin/ferroportin system is built and demonstrates that inflammation mainly reduces the amount of iron in the blood stream by reducing intracellular ferro portin transcription, and not by hePCidin-dependent ferroportIn protein destabilization.

Iron metabolism and related genetic diseases: A cleared land, keeping mysteries.

Expression of hepcidin and ferroportin in full term placenta of pregnant cows.

...

References

SHOWING 1-10 OF 291 REFERENCES

Hepcidin and iron regulation, 10 years later.

Modulation of hepcidin and ferroportin expression during infection and inflammation couples iron metabolism to host defense and decreases iron availability to invading pathogens.

Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization

It is reported that hepcidin bound to ferroportin in tissue culture cells, leading to decreased export of cellular iron and the posttranslational regulation of ferroports by hePCidin may complete a homeostatic loop.

Regulation of iron transport and the role of transferrin.

ER Stress Controls Iron Metabolism Through Induction of Hepcidin

It is found that endoplasmic reticulum (ER) stress also induces hepcidin expression and causes hypoferremia and spleen iron sequestration in mice, suggesting a direct link between the intracellular stress response, innate immunity, and iron metabolism.

Hepcidin in iron overload disorders.

Hepcidin was found to be suppressed in patients with thalassemia syndromes and congenital dyserythropoietic anemia type 1 and was undetectable in patientswith juvenile hemochromatosis with HAMP mutations, and urine hepcidin levels were significantly elevated in 2 patients with hemochROMatosis type 4.

Hepcidin targets ferroportin for degradation in hepatocytes

Hepcidin can trigger ferroportin degradation in hepatocytes, which must be taken into account when considering hepcidin therapeutics, which is shown to support the centrolobular iron deposition observed in mice.

Targeting the Hepcidin Pathway with RNAi Therapeutics for the Treatment of Anemia

Small interfering RNAs (siRNAs) were developed against HAMP, the hepcidin gene, as well as other targets involved in iron metabolism, both as a means to identify a therapeutic for the treatment of anemia and as a Means to further characterize the hePCidin signaling pathway.

The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis.

Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance.

It is shown that BMP-2 administration increases hepcidin expression and decreases serum iron levels in vivo and that soluble hemojuvelin (HJV.Fc) selectively inhibits BMP induction of hepcIDin expression in vitro and this data support a role for modulators of the BMP signaling pathway in treating diseases of iron overload and anemia of chronic disease.
...